HomeAll New Products Listed Chronologically

All New Products Listed Chronologically

Catalog No. Product Name Information Isotype
A2356 Refanezumab (Anti-Siglec-4a / MAG) Refanezumab (Anti-Siglec-4a / MAG) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. MW : 145.5 KD Aug 10 2023
A2357 Vadastuximab (Anti-Siglec-3 / CD33) Vadastuximab (Anti-Siglec-3 / CD33) is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine. MW : 150 KD. Aug 10 2023
A2358 Inotuzumab (Anti-Siglec-2 / CD22) Inotuzumab (Anti-Siglec-2 / CD22) is a humanized IgG4, κ monoclonal antibody that targets CD22. Inotuzumab can be used for the research of acute lymphoblastic leukaemia and non-Hodgkin lymphoma. MW : 144.78 kD. Aug 10 2023
A2359 Anti-Sialyl-Lewis A Anti-Sialyl-Lewis A is a human monoclonal antibody against the carbohydrate antigen sialyl-Lewis A (carbohydrate antigen 19-9; CA19-9) with potential antineoplastic activity.MW : 145.5 kD. Aug 10 2023
A2360 Dezamizumab (Anti-Serum Amyloid P / SAP) Dezamizumab (Anti-Serum Amyloid P / SAP) is a fully humanized recombinant monoclonal IgG1 anti-serum amyloid P component (SAP) antibody with potential anti-amyloid activity. MW : 144.18 kD. Aug 10 2023
A2361 Pepinemab (Anti-SEMA4D / CD100) Pepinemab (Anti-SEMA4D / CD100) is a human monoclonal antibody against SEMA4D, a signalling protein 4D (SEMA4D), which is a regulator of neuronal development and plays a role in a variety of cellular processes. MW : 145.5 kD. Aug 10 2023
A2362 Anti-SCFR / c-Kit / CD117 Anti-SCFR / c-Kit / CD117 is a humanized monoclonal antibody against the stem cell factor receptor c-Kit (SCFR) with potential antineoplastic activity. MW : 150 kD. Aug 10 2023
A2363 Anti-RTN4 / NOGO Anti-RTN4 / NOGO is an antibody acting against anti-RTN4. MW : 145.4 kD. Aug 10 2023
A2364 Palivizumab (Anti-RSV-F) Palivizumab (Anti-RSV-F) is a humanized monoclonal antibody against the fusion protein (F protein) of human respiratory syncytial virus (RSV), with prophylactic application in respiratory syncytial virus infections. MW : 145.5 kD. Aug 10 2023
A2365 Rosmantuzumab (anti-RSPO3) Rosmantuzumab (OMP-131R10) is an immunoglobulin (Ig) G1 humanized monoclonal antibody targeting human R-spondin 3 (RSPO3) with potential immunostimulating and antineoplastic activities. MW: 145.5 kD. Aug 10 2023
A2366 Zilovertamab (Anti-ROR1) Zilovertamab (Anti-ROR1) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling with potential antineoplastic activity. MW: 145.5 kD. Aug 10 2023
A2367 Anti-ROBO1(Asclepius Technology patent anti-Robo1 CAR) Anti-ROBO1 (Asclepius Technology patent anti-Robo1 CAR) is a bispecific antigen-binding construct targeting ROBO1, with a single-chain variable region antibody fragment ScFV binding to the surface antigen of immune cells and a Slit2D2 protein fragment binding to the surface antigen Robo1 of tumour cells.MW: 145.5 kD. Aug 10 2023
A2368 Roledumab (Anti-RHD / CD240d) Roledumab (Anti-RHD / CD240d) is a human recombinant monoclonal anti-RhD antibody with the potential to prevent RhD allo-immunization. MW: 145.5 kD. Aug 10 2023
A2369 Anti-RGMC / HFE2 Anti-RGMC / HFE2 is a humanized monoclonal antibody directed against the bone morphogenetic proteins (BMPs) co-receptor hemojuvelin (HJV) with potential to treat anemia of inflammation and other forms of anemia. MW: 145.5 kD. Aug 10 2023
E1428 Mps1-IN-6 (Compound 9) Mps1-IN-6 (Compound 9) is a potent Mps1 inhibitor with IC50 of 6.4 nM. It also exhibits antiproliferative and anti-tumor activity in breast cancer cells. Aug 10 2023
E2978 TMRE TMRE (Tetramethylrhodamine ethyl ester perchlorate, TMRE perchlorate) is a non-cytotoxic cell-permeant fluorogenic dye most commonly used to assess mitochondrial function using live cell fluorescence microscopy and flow cytometry. Aug 09 2023
E1375 JKE-1674 JKE-1674 is an analog of ML-210 in which the nitroisoxazole ring is replaced with an α-nitroketoxime. It is an orally active inhibitor of glutathione peroxidase 4 (GPX4) and also is an active metabolite of GPX4 inhibitor ML-210. JKE-1674 can convert into a nitrile oxide JKE-1777. Aug 06 2023
E1432 TPH104m TPH104m is a thienopyrimidine-hydrazinyl analog that inhibits Drp1 phosphorylation and induces non-apoptotic TNBC cell death. It also significantly inhibits TNBC proliferation. Aug 06 2023
E1353 AZD1656 AZD1656 is a potent, selective and orally active activator of glucokinase. AZD1656 has the potential for type 2 diabetes research. Aug 03 2023
E1503 TRC102 (methoxyamine hydrochloride) TRC102 (methoxyamine hydrochloride, O-Methylhydroxylamine hydrochloride) is a reagent used for the preparation of O-methyl oximes or the synthesis of O-methyl oximes from aldehydes. Aug 02 2023